AdBio partners logo

AdBio partners

Europe, Ile-de-France, France, Paris

Description

AdBio partners is a venture capital fund supported in particular by the National Seed-Fund.

Investor Profile

AdBio partners has made 27 investments, with 4 in the past 12 months and 44% as lead.

Stage Focus

  • Seed (48%)
  • Series A (19%)
  • Series Unknown (19%)
  • Series B (7%)
  • Series C (4%)
  • Series D (4%)

Country Focus

  • France (52%)
  • Belgium (26%)
  • Spain (15%)
  • United Kingdom (4%)
  • Denmark (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Biopharma
  • Life Science
  • Therapeutics
  • Medical
  • Product Research
  • Manufacturing
  • Bioinformatics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AdBio partners frequently co-invest with?

Omnes Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 3
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 4
Asabys Partners
Europe, Catalonia, Spain, Barcelona
Co-Investments: 4
Gemma Frisius Fund
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 3
VIB
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 3
Invivo Capital Partners
Europe, Catalonia, Spain, Barcelona
Co-Investments: 3
V-Bio Ventures
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 5
Pontifax
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 3
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 3
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 3

What are some of recent deals done by AdBio partners?

Augustine Therapeutics

Leuven, Vlaams-Brabant, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

BiopharmaBiotechnologyPharmaceutical
Series AMar 24, 2025
Amount Raised: $84,139,626
Cephagenix

Glostrup, Hovedstaden, Denmark

Cephagenix focuses on identifying and developing new, effective migraine therapies.

Health CareHealth DiagnosticsMedicalWellness
SeedJan 16, 2025
Amount Raised: $9,259,669
Tenpoint Therapeutics

Camborne, Cornwall, United Kingdom

Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.

BiotechnologyProduct Research
Series UnknownDec 11, 2024
Augustine Therapeutics

Leuven, Vlaams-Brabant, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

BiopharmaBiotechnologyPharmaceutical
Series AJun 26, 2024
Amount Raised: $18,206,938
AgomAb Therapeutics

Ghent, Oost-Vlaanderen, Belgium

AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues.

BiotechnologyHealth CareTherapeutics
Series COct 11, 2023
Amount Raised: $100,817,696
Orikine Bio

Barcelona, Catalonia, Spain

Orikine Bio is a pioneer biotech company in the field of tailored cytokines for the treatment of immune-mediated disorders.

BiotechnologyMedicalProduct Research
SeedJul 18, 2023
Amount Raised: $6,175,633
Astraveus

Paris, Ile-de-France, France

Astraveus is developing the next generation of cell and gene therapy (CGT) manufacturing solutions.

BioinformaticsBiotechnologyLife Science
SeedJun 27, 2023
Amount Raised: $18,079,953
Anoat Therapeutics

Paris, Ile-de-France, France

Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis.

BiopharmaBiotechnologyPharmaceuticalProduct ResearchTherapeutics
SeedJun 19, 2023
Amount Raised: $2,184,749
DiogenX

Marseille, Provence-Alpes-Cote d'Azur, France

DiogenX is a preclinical stage biotech company specializing in the development of pancreatic beta-cell modulators.

BiotechnologyLife Science
Series AMay 10, 2023
Amount Raised: $36,792,809
ARTHEx Biotech

Valencia, Comunidad Valenciana, Spain

AntagomiR oligonucleotides to treat Myotonic Dystrophy patients.

Biotechnology
Series BMay 3, 2023
Amount Raised: $46,487,689